29
th
International Conference on Cancer Research and Pharmacology
Theme:
Innovations in Cancer Research
Date:
May 19- 20, 2020
Conference Venue:
London, UK
Menu
Home
Call for abstracts- Sessions
Conference Brochure
Abstract Submission
Venue
Monday, August 19, 2019
Recent Trends in Oncology
FDA has approved fedratinib for intermediate-2 or high-risk primary or secondary myelofibrosis. Learn more about oncology at:
http://bit.ly/2Yxiv66
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment